JP2021529752A5 - - Google Patents
Info
- Publication number
- JP2021529752A5 JP2021529752A5 JP2020572891A JP2020572891A JP2021529752A5 JP 2021529752 A5 JP2021529752 A5 JP 2021529752A5 JP 2020572891 A JP2020572891 A JP 2020572891A JP 2020572891 A JP2020572891 A JP 2020572891A JP 2021529752 A5 JP2021529752 A5 JP 2021529752A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- alkoxy
- group
- heteroaryl
- aryl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862763735P | 2018-06-29 | 2018-06-29 | |
| US62/763,735 | 2018-06-29 | ||
| PCT/US2019/040121 WO2020006557A1 (en) | 2018-06-29 | 2019-07-01 | Compositions and methods of using itaconic acid derivatives |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021529752A JP2021529752A (ja) | 2021-11-04 |
| JP2021529752A5 true JP2021529752A5 (https=) | 2022-06-21 |
| JP7396682B2 JP7396682B2 (ja) | 2023-12-12 |
Family
ID=68985877
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020572891A Active JP7396682B2 (ja) | 2018-06-29 | 2019-07-01 | イタコン酸誘導体の組成物及び使用方法 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US12060310B2 (https=) |
| EP (1) | EP3813815B1 (https=) |
| JP (1) | JP7396682B2 (https=) |
| ES (1) | ES3063485T3 (https=) |
| WO (1) | WO2020006557A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2021013299A (es) | 2019-04-30 | 2022-01-31 | Sitryx Therapeutics Ltd | Derivados de acido itaconico y usos de estos en el tratamiento de una enfermedad inflamatoria asociada con una respuesta inmunitaria indeseable. |
| EP4237404A1 (en) * | 2020-10-29 | 2023-09-06 | Sitryx Therapeutics Limited | Novel compounds |
| WO2022223778A1 (en) | 2021-04-23 | 2022-10-27 | Helmholtz-Zentrum für Infektionsforschung GmbH | Citraconic acid and derivatives thereof for use as a medicament |
| CN119685257B (zh) * | 2024-12-16 | 2026-02-27 | 华中科技大学同济医学院附属协和医院 | 体外诱导t细胞免疫记忆分化的方法及应用 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5260479A (en) | 1991-12-16 | 1993-11-09 | Merck & Co., Inc. | Inhibitors of farnesyl protein transferase |
| EP1062954B1 (en) * | 1998-10-27 | 2007-05-30 | Suntory Limited | Use of itaconic acid for regulation of glycolytic metabolism |
| US8293925B2 (en) | 2009-09-21 | 2012-10-23 | Chemocentryx, Inc. | Pyrrolidinone carboxamide derivatives |
| LU91877B1 (en) | 2011-09-23 | 2013-03-25 | Univ Luxembourg | Method to predict the presence of itaconic Acid, IRG1 and/or protein IRG1 in a subject and pharmaceutical composition for performing gene therapy |
| US8691993B2 (en) | 2011-12-12 | 2014-04-08 | Hoffmann-La Roche Inc. | Piperidinyl naphthylacetic acids |
| EP2833877A4 (en) | 2012-04-03 | 2015-11-25 | Aposense Ltd | NEW TARGETING AGENTS FOR DIAGNOSTIC AND THERAPEUTIC INDICATIONS |
| EP3416634A4 (en) | 2016-02-15 | 2019-10-09 | Artyomov, Maxim | IMMUNOMODULATORY AGENTS AND METHOD FOR USE THEREOF |
-
2019
- 2019-07-01 US US17/255,150 patent/US12060310B2/en active Active
- 2019-07-01 JP JP2020572891A patent/JP7396682B2/ja active Active
- 2019-07-01 EP EP19826034.1A patent/EP3813815B1/en active Active
- 2019-07-01 ES ES19826034T patent/ES3063485T3/es active Active
- 2019-07-01 WO PCT/US2019/040121 patent/WO2020006557A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021529752A5 (https=) | ||
| JP2021534124A5 (https=) | ||
| JP2004523561A5 (https=) | ||
| AR078542A1 (es) | Moduladores de gpr40 de pirrolidina | |
| JP2011530500A5 (https=) | ||
| RU2015148010A (ru) | Высокоактивное производное нуклеозида для лечения hcv | |
| CA2565599A1 (en) | Substituted 2-quinolyl-oxazoles useful as pde4 inhibitors | |
| JP2022521797A5 (https=) | ||
| PE20090630A1 (es) | Derivados de indol 2-carboxi sustituidos y metodos para su utilizacion | |
| AR053195A1 (es) | Compuestos inhibidores de dipeptidil peptidasa-iv metodos para preparar los mismos y composiciones farmaceuticas que los contienen como un agente activo | |
| RU2400483C2 (ru) | Пуриновые производные в качестве агонистов рецептора a2a | |
| PE20140608A1 (es) | Analogos de nucleotidos sustituidos | |
| PE20070751A1 (es) | Derivados de isoxazolidina como inhibidores de la interaccion de proteinas bcl | |
| RU2010116253A (ru) | Производные n-гидроксилсульфонамида как новые физиологически применимые доноры нитроксила | |
| AR037355A1 (es) | Compuesto derivado de difenilamina, composicion farmaceutica y su uso en la fabricacion de medicamentos | |
| RU2011140064A (ru) | Ингибиторы тирозинкиназы брутона | |
| RU2008143001A (ru) | 5-амидозамещенные пиримидины, ингибирующие вич | |
| AR067896A1 (es) | Procedimiento para sintetizar compuestos utiles para tratar hepatitis c | |
| RU2010106393A (ru) | Новые микробиоциды | |
| CA2439410A1 (en) | Analogs of thalidomide as potential angiogenesis inhibitors | |
| AR049124A1 (es) | Compuestos de de pirimidinona como inhibidores de la integrasa del virus hiv, composiciones farmaceuticas que las contienen y su uso en el tratamiento del sida y de la infeccion por hiv | |
| RU2008152087A (ru) | Макроциклические оксимильные ингибиторы протеазы гепатита | |
| AR073922A1 (es) | 2- oxoquinoxalinas como bloqueadores de los canales de sodio tardios | |
| RU2017123114A (ru) | 3-оксо-3-(ариламино)пропионаты, способ их получения и их применение в получении пирролидинонов | |
| WO2008078196A3 (en) | Substituted heteroaryl pyridopyrimidone derivatives |